EU BIOTECH CAMPUS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
EU BIOTECH CAMPUS
Largest movements
- Tangible fixed assets +€5.4m
up €5.4m (+269%), from €2.0m to €7.5m
of which Assets under construction and advance payments: +€5.4m
- Cash -€2.3m
down €2.3m (-91.6%), from €2.5m to €210,543
mainly Investment in fixed assets (net) (-€5.4m) and Receivables within one year (-€859,452)
- Receivables within one year +€859,452
up €859,452 (+3,048%), from €28,198 to €887,650
- Debts within one year +€4.4m
up €4.4m (+2,567%), from €170,013 to €4.5m
of which Trade debts: +€3.5m
- Investment grants -€200,766
down €200,766 (-4.3%), from €4.7m to €4.5m
- Profit (loss) carried forward -€175,235
down €175,235 (-68.0%), from -€257,870 to -€433,105
- Gross operating margin +€408,689
up €408,689, from -€318,967 to €89,721
- Staff costs +€274,703
new in 2024: €274,703
- Financial income -€13,209
down €13,209 (-44.3%), from €29,806 to €16,597
- Depreciation +€3,236
up €3,236 (+141%), from €2,288 to €5,524
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,572,143 | €8,560,598 | +€4.0m | +87.2% |
| Fixed assets | 21/28 | €2,022,624 | €7,458,550 | +€5.4m | +269% |
| Intangible fixed assets | 21 | €5,893 | €6,211 | +€318 | +5.4% |
| Tangible fixed assets | 22/27 | €2,016,731 | €7,451,515 | +€5.4m | +269% |
| Land and buildings | 22 | €47,328 | €47,328 | = | 0.0% |
| Furniture and vehicles | 24 | - | €11,519 | +€11,519 | |
| Assets under construction and advance payments | 27 | €1,969,403 | €7,392,668 | +€5.4m | +275% |
| Financial fixed assets | 28 | - | €825 | +€825 | |
| Current assets | 29/58 | €2,549,519 | €1,102,048 | -€1.4m | -56.8% |
| Amounts receivable within one year | 40/41 | €28,198 | €887,650 | +€859,452 | +3,048% |
| Other amounts receivable | 41 | €28,198 | €887,650 | +€859,452 | +3,048% |
| Cash at bank and in hand | 54/58 | €2,510,526 | €210,543 | -€2.3m | -91.6% |
| Deferred charges and accrued income | 490/1 | €10,795 | €3,854 | -€6,941 | -64.3% |
| Total equity and liabilities | 10/49 | €4,572,143 | €8,560,598 | +€4.0m | +87.2% |
| Equity | 10/15 | €4,402,130 | €4,026,129 | -€376,001 | -8.5% |
| Profit (loss) carried forward | 14 | -€257,870 | -€433,105 | -€175,235 | -68.0% |
| Investment grants | 15 | €4,660,000 | €4,459,234 | -€200,766 | -4.3% |
| Amounts payable | 17/49 | €170,013 | €4,534,469 | +€4.4m | +2,567% |
| Amounts payable within one year | 42/48 | €170,013 | €4,534,469 | +€4.4m | +2,567% |
| Financial debts | 43 | - | €200,000 | +€200,000 | |
| Credit institutions | 430/8 | - | €200,000 | +€200,000 | |
| Trade debts | 44 | €170,013 | €3,643,162 | +€3.5m | +2,043% |
| Suppliers | 440/4 | €170,013 | €3,643,162 | +€3.5m | +2,043% |
| Taxes, remuneration and social security | 45 | - | €31,308 | +€31,308 | |
| Taxes | 450/3 | - | €31,308 | +€31,308 | |
| Remuneration, social security and pensions | 62 | - | €274,703 | +€274,703 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,288 | €5,524 | +€3,236 | +141% |
| Other operating charges | 640/8 | €711 | €829 | +€117 | +16.5% |
| Gross operating margin | 9900 | -€318,967 | €89,721 | +€408,689 | |
| Operating profit (loss) | 9901 | -€321,966 | -€191,334 | +€130,633 | +40.6% |
| Financial income | 75/76B | €29,806 | €16,597 | -€13,209 | -44.3% |
| Recurring financial income | 75 | €29,806 | €16,597 | -€13,209 | -44.3% |
| Financial charges | 65/66B | €256 | €498 | +€243 | +94.8% |
| Recurring financial charges | 65 | €256 | €498 | +€243 | +94.8% |
| Profit (loss) for the period before taxes | 9903 | -€292,416 | -€175,235 | +€117,181 | +40.1% |
| Profit (loss) for the period | 9904 | -€292,416 | -€175,235 | +€117,181 | +40.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€292,416 | -€175,235 | +€117,181 | +40.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.